Lotus Eye Hospital and Institute Croissance future
Future contrôle des critères 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Lotus Eye Hospital and Institute.
Informations clés
n/a
Taux de croissance des bénéfices
n/a
Taux de croissance du BPA
Healthcare croissance des bénéfices | 26.4% |
Taux de croissance des recettes | n/a |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | None |
Dernière mise à jour | n/a |
Mises à jour récentes de la croissance future
Pas de mise à jour
Recent updates
Optimistic Investors Push Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) Shares Up 25% But Growth Is Lacking
Aug 21Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) Price Is Out Of Tune With Earnings
Jan 24Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50
Sep 08We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease
Jul 15Here's Why Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Has Caught The Eye Of Investors
Apr 07We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease
Oct 08Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50
Sep 02If EPS Growth Is Important To You, Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Presents An Opportunity
Jun 17MD & Whole Time Director Sangeetha Sundaramoorthy Just Bought 2.8% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
Mar 11Chief Executive Officer K. Ramalingam Just Bought 122% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
Dec 30Insider Buying: The Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) MD & Whole Time Director Just Bought 2.8% More Shares
Nov 20The Chief Executive Officer of Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE), K. Ramalingam, Just Bought 17% More Shares
Sep 21Why Investors Shouldn't Be Surprised By Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) P/E
Aug 27Should You Take Comfort From Insider Transactions At Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)?
Aug 03Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) P/E Isn't Throwing Up Surprises
Jul 06Dans cette section, nous présentons généralement des projections de croissance du chiffre d'affaires et des bénéfices basées sur les estimations consensuelles d'analystes professionnels afin d'aider les investisseurs à comprendre la capacité de l'entreprise à générer des bénéfices. Mais comme Lotus Eye Hospital and Institute n'a pas fourni suffisamment de données passées et n'a pas de prévisions d'analystes, ses bénéfices futurs ne peuvent pas être calculés de manière fiable en extrapolant les données passées ou en utilisant les prévisions des analystes.
Il s'agit d'une situation assez rare car 97% des entreprises couvertes par SimplyWall St disposent de données financières passées.
Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
6/30/2024 | 485 | 22 | N/A | N/A | N/A |
3/31/2024 | 482 | 29 | 0 | 57 | N/A |
12/31/2023 | 485 | 35 | N/A | N/A | N/A |
9/30/2023 | 486 | 40 | -1 | 57 | N/A |
6/30/2023 | 477 | 41 | N/A | N/A | N/A |
3/31/2023 | 470 | 41 | 13 | 44 | N/A |
12/31/2022 | 464 | 40 | N/A | N/A | N/A |
9/30/2022 | 459 | 42 | 13 | 69 | N/A |
6/30/2022 | 449 | 46 | N/A | N/A | N/A |
3/31/2022 | 389 | 30 | -3 | 44 | N/A |
12/31/2021 | 389 | 36 | N/A | N/A | N/A |
9/30/2021 | 372 | 32 | 37 | 49 | N/A |
6/30/2021 | 335 | 20 | N/A | N/A | N/A |
3/31/2021 | 324 | 16 | 23 | 27 | N/A |
12/31/2020 | 300 | -5 | N/A | N/A | N/A |
9/30/2020 | 301 | -14 | 8 | 26 | N/A |
6/30/2020 | 335 | -6 | N/A | N/A | N/A |
3/31/2020 | 406 | 11 | 26 | 50 | N/A |
12/31/2019 | 420 | 21 | N/A | N/A | N/A |
9/30/2019 | 415 | 20 | N/A | N/A | N/A |
6/30/2019 | 401 | 11 | N/A | N/A | N/A |
3/31/2019 | 384 | 7 | -5 | 42 | N/A |
12/31/2018 | 382 | 7 | N/A | N/A | N/A |
9/30/2018 | 381 | 9 | N/A | N/A | N/A |
6/30/2018 | 384 | 14 | N/A | N/A | N/A |
3/31/2018 | 380 | 17 | N/A | 58 | N/A |
12/31/2017 | 373 | 8 | N/A | N/A | N/A |
9/30/2017 | 359 | 4 | N/A | N/A | N/A |
6/30/2017 | 350 | 6 | N/A | N/A | N/A |
3/31/2017 | 340 | 4 | N/A | 30 | N/A |
12/31/2016 | 330 | 7 | N/A | N/A | N/A |
9/30/2016 | 324 | 7 | N/A | N/A | N/A |
6/30/2016 | 314 | 0 | N/A | N/A | N/A |
3/31/2016 | 311 | 1 | N/A | 34 | N/A |
12/31/2015 | 311 | -5 | N/A | N/A | N/A |
9/30/2015 | 315 | -6 | N/A | N/A | N/A |
6/30/2015 | 308 | -14 | N/A | N/A | N/A |
3/31/2015 | 302 | -20 | N/A | 24 | N/A |
12/31/2014 | 298 | -12 | N/A | N/A | N/A |
9/30/2014 | 290 | -9 | N/A | N/A | N/A |
6/30/2014 | 289 | 1 | N/A | N/A | N/A |
3/31/2014 | 288 | 0 | N/A | 44 | N/A |
12/31/2013 | 287 | 4 | N/A | N/A | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: Insufficient data to determine if LOTUSEYE's forecast earnings growth is above the savings rate (6.7%).
Bénéfices vs marché: Insufficient data to determine if LOTUSEYE's earnings are forecast to grow faster than the Indian market
Croissance élevée des bénéfices: Insufficient data to determine if LOTUSEYE's earnings are expected to grow significantly over the next 3 years.
Chiffre d'affaires vs marché: Insufficient data to determine if LOTUSEYE's revenue is forecast to grow faster than the Indian market.
Croissance élevée des revenus: Insufficient data to determine if LOTUSEYE's revenue is forecast to grow faster than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if LOTUSEYE's Return on Equity is forecast to be high in 3 years time